Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice
David J. Pinato, Thomas U. Marron, Pallavi Shruti Mishra-Kalyani, Yutao Gong, Guo Wei, David Szafron, Elad Sharon, Anwaar Saeed, Tomi Jun, Sirish Dharmapuri, Abdul R. Naqash, Thoetchai Peeraphatdit, Anuhya Gampa, Yinghong Wang, Uqba Khan, Mahvish Muzaffar, Musharraf Navaid, Chieh J. Lee, Pei Chang Lee, Anushi BulumulleBo Yu, Sonal Paul, Neil Nimkar, Dominik Bettinger, Hannah Hildebrand, Yehia I. Abugabal, Tiziana Pressiani, Nicola Personeni, Antonio D'Alessio, Ahmed O. Kaseb, Yi Hsiang Huang, Celina Ang, Julie Schneider, Anjana Pillai, Lorenza Rimassa, Kirsten B. Goldberg, Richard Pazdur, Marc Theoret, Steven Lemery, ‘Lola Fashoyin-Aje, Alessio Cortellini, Lorraine Pelosof
Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review
Fingerprint
Entra nei temi di ricerca di 'Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice'. Insieme formano una fingerprint unica.